Welcome to the latest edition of DNA Dispatch, the quarterly newsletter from OGT, your hybridisation experts.
We're delighted to announce that our OGT website has been updated with exciting new features designed to enhance your experience, including:
Ready to explore the new OGT website?
Check out our recent article, "Partnering with OGT: Empowering the establishment of a FISH laboratory in Nigeria", to learn about how our experts are helping labs all over the world reach their goals.
Want to get caught up on some of the latest research shared at the conference?
We're excited to share a presentation on a custom SureSeq™ panel, the Somatic Myeloid Lymphoid Panel (SMyLyP), given by Laura Semenuk (Queen's University, Kingston, ON, CA) at GLGC in May titled, "SMyLyP: How one integrated laboratory test can detect both molecular and cytogenetic driving alterations across blood cancer."
Haematological malignancies such as ALL and MDSs are characterised by complex mutations that can vary widely between patients and change over the course of the disease. Documenting the frequency and presence of rare mutations drives understanding of patient prognosis and response to treatment.
See how CytoSure® arrays are driving research in haematological malignancies across the world*:
→ Cryptic rearrangement of the KMT2A gene in a B-cell ALL
→ Genomic landscape of childhood ALL in Malaysia
→ Complex genetic evolution and treatment challenges in myeloid neoplasms
Learn more about our SureSeq NGS myeloid genomic solutions at work through two scientific posters, authored by Marzena Wojtaszewska, Coordinator of the Molecular Biology, Laboratory, Rzeszow, Poland.
View the scientific posters:
Our latest article explores the important balance between sequencing depth and sequencing batching in NGS.
By strategically optimising depth and batching laboratories will be able to achieve cost-efficiency whilst maintaining the sensitivity required for clinical decision-making in cancer genomics.
Don’t forget…Our FAS team can be contacted online with free support advice
*Providing links to these publications is intended for educational purposes only and does not replace independent professional judgment. Statements of fact and opinions expressed are those of the publications’ authors and, unless expressly stated to the contrary, are not the opinion or position of the Oxford Gene Technology Group (OGT). OGT does not endorse or approve, and assumes no responsibility for, the content, accuracy or completeness of the information presented in these publications.
Visit USA site
Visit Canada site
